Literature DB >> 26047042

Changes in Matrix Metalloproteinases in Diabetes Patients' Tears After Vitrectomy and the Relationship With Corneal Epithelial Disorder.

Takehiro Matsumura, Yoshihiro Takamura, Takeshi Tomomatsu, Shogo Arimura, Makoto Gozawa, Yuji Takihara, Masaru Inatani.   

Abstract

PURPOSE: Previous studies indicate involvement of matrix metalloproteinases (MMPs) in the pathogenesis of diabetic keratopathy. To evaluate MMP levels in the tears of patients with diabetes, we investigated changes in MMP levels during perioperative periods and clarify the relationship with corneal epithelial disorders following vitrectomy.
METHODS: Matrix metalloproteinase levels in tears were measured by multiplex bead array in patients with or without diabetes who were scheduled for vitrectomy. Twenty-two patients with diabetes and proliferative diabetic retinopathy, and 20 patients with epiretinal membrane or macular hole (control group), were recruited. Changes in MMP levels during perioperative periods and the relationship with corneal epithelial disorders after vitrectomy were analyzed.
RESULTS: The levels of MMP-2, -9, and -10 at 1 day after surgery in the diabetic group were significantly higher than in the control group. At 1 week after surgery, MMP-10 levels in the diabetic group were significantly higher than in the control group. After vitrectomy, corneal epithelial disorders occurred in six patients in the diabetic group but not in the control group. In the diabetic group, MMP-10 levels in tears of patients with corneal epithelial disorders were significantly higher than those in patients without corneal epithelial disorders.
CONCLUSIONS: The MMP concentration in tears of patients with diabetes was higher than in nondiabetic patients after vitrectomy. High MMP-10 levels were observed in patients with diabetes and corneal epithelial disorders after vitrectomy. Aberrant levels of MMP-10 may cause corneal epithelial disorder after vitrectomy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26047042     DOI: 10.1167/iovs.15-16489

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  5 in total

1.  Putative Biomarkers in Tears for Diabetic Retinopathy Diagnosis.

Authors:  Madania Amorim; Beatriz Martins; Francisco Caramelo; Conceição Gonçalves; Grimalde Trindade; Jorge Simão; Patrícia Barreto; Inês Marques; Ermelindo Carreira Leal; Eugénia Carvalho; Flávio Reis; Teresa Ribeiro-Rodrigues; Henrique Girão; Paulo Rodrigues-Santos; Cláudia Farinha; António Francisco Ambrósio; Rufino Silva; Rosa Fernandes
Journal:  Front Med (Lausanne)       Date:  2022-05-25

2.  Nuclear translocation of β-catenin induced by E-cadherin endocytosis causes recurrent erosion of diabetic cornea.

Authors:  Wenbei Ma; Zhengyuan Xie; Hui Chen; Lina Zeng; Xiaohong Chen; Songfu Feng; Xiaohe Lu
Journal:  Exp Biol Med (Maywood)       Date:  2021-02-07

Review 3.  Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine.

Authors:  Suzanne Hagan; Eilidh Martin; Amalia Enríquez-de-Salamanca
Journal:  EPMA J       Date:  2016-07-13       Impact factor: 6.543

Review 4.  Matrix Metalloproteinases in Age-Related Macular Degeneration (AMD).

Authors:  Luis García-Onrubia; Fco Javier Valentín-Bravo; Rosa M Coco-Martin; Rogelio González-Sarmiento; J Carlos Pastor; Ricardo Usategui-Martín; Salvador Pastor-Idoate
Journal:  Int J Mol Sci       Date:  2020-08-18       Impact factor: 5.923

5.  Topical bromfenac reduces multiple inflammatory cytokines in the aqueous humour of pseudophakic patients.

Authors:  Takehiro Matsumura; Kentaro Iwasaki; Shogo Arimura; Ryuji Takeda; Yoshihiro Takamura; Masaru Inatani
Journal:  Sci Rep       Date:  2021-03-16       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.